Merck’s (MRK) Hopes Crushed

Merck (MRK) had high hopes for its cholesterol drug Cordaptive

According to The Wall Street Journal, things did not work out. The paper reports that the agency issuing a "not approvable" letter for the potential blockbuster.

Douglas A. McIntyre